Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
19615-4 N-desalkylflurazepam PrThr Urine Pt Ord Confirm   ACTIVE N-desalkylflurazepam [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19615-4   Confirm     Both       0 Desalkylfluraz Ur Ql Cfm           Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; LC/MS/MS; norfludiazepam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19617-0 N-desalkylflurazepam MCnc Urine Pt Qn     ACTIVE N-desalkylflurazepam [Mass/volume] in Urine   MIN DefinitionDescription     ug/mL             DRUG/TOX   19617-0         Both       0 Desalkylfluraz Ur-mCnc       Y   Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l               ug/mL       0
19618-8 N-desalkylflurazepam cutoff MCnc Urine Pt Qn Screen   ACTIVE N-desalkylflurazepam cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19618-8   Screen     Observation       0 Desalkylfluraz CtO Ur Scn-mCnc       Y   CtO; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19619-6 N-desalkylflurazepam cutoff MCnc Urine Pt Qn Confirm   ACTIVE N-desalkylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19619-6   Confirm     Observation       0 Desalkylfluraz CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; LC/MS/MS; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l               ng/mL       0
1962-0 Bicarbonate SCnc Plas Pt Qn     DEPRECATED Deprecated Bicarbonate [Moles/volume] in Plasma   DEL DefinitionDescription     mmol/L             CHEM   1962-0         Both       0 Deprecated HCO3 Plas-sCnc       Y   BIC; bicar; Bicarb; Chemistry; HCO3; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.7 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
19620-4 Nitrazepam PrThr Urine Pt Ord Screen   ACTIVE Nitrazepam [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19620-4   Screen     Both       0 Nitrazepam Ur Ql Scn           Alodorm; APODORM; AREM; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; Imeson; Insoma; Ipersed; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ordinal; Ormodon; Paxadorm; Pelson; Point in time; PR; QL; Qual; Qualitative; Random; Remnos; Scn; Scr; Screen; Scrn; Serenade; Somnibel n; Somniper; Somnite; Surem; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19621-2 Nitrazepam PrThr Urine Pt Ord Confirm   ACTIVE Nitrazepam [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19621-2   Confirm     Both       0 Nitrazepam Ur Ql Cfm           Alodorm; APODORM; AREM; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; GCMS; Imeson; Insoma; Ipersed; LC/MS/MS; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ordinal; Ormodon; Paxadorm; Pelson; Point in time; PR; QL; Qual; Qualitative; Random; Remnos; Screen; Serenade; Somnibel n; Somniper; Somnite; Surem; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19622-0 Nitrazepam cutoff MCnc Urine Pt Qn Screen   ACTIVE Nitrazepam cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19622-0   Screen     Observation       0 Nitrazepam CtO Ur Scn-mCnc       Y   Alodorm; APODORM; AREM; CtO; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; Imeson; Insoma; Ipersed; Level; Mass concentration; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Scn; Scr; Scrn; Serenade; Somnibel n; Somniper; Somnite; Surem; UA; UR; Urn 2.44 1.0l               ng/mL       0
19623-8 Nitrazepam cutoff MCnc Urine Pt Qn Confirm   ACTIVE Nitrazepam cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19623-8   Confirm     Observation       0 Nitrazepam CtO Ur Cfm-mCnc       Y   Alodorm; APODORM; AREM; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; GCMS; Imeson; Insoma; Ipersed; LC/MS/MS; Level; Mass concentration; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; Somnibel n; Somniper; Somnite; Surem; UA; UR; Urn 2.44 1.0l               ng/mL       0
19624-6 Nordiazepam PrThr Urine Pt Ord Screen   ACTIVE Nordiazepam [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19624-6   Screen     Both       0 Nordiazepam Ur Ql Scn           Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Madar; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Ordinal; Point in time; PR; Praxadium; Prazepam metabolite; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Stilny; Tranxilium N; UA; UR; Urn; Vegesan 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19626-1 Nordiazepam cutoff MCnc Urine Pt Qn Screen   ACTIVE Nordiazepam cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19626-1   Screen     Observation       0 Nordiazepam CtO Ur Scn-mCnc       Y   Calmday; Chlordiazepoxide metabolite; CtO; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Stilny; Tranxilium N; UA; UR; Urn; Vegesan 2.44 1.0l               ng/mL       0
19627-9 Nordiazepam cutoff MCnc Urine Pt Qn Confirm   ACTIVE Nordiazepam cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19627-9   Confirm     Observation       0 Nordiazepam CtO Ur Cfm-mCnc       Y   Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; UA; UR; Urn; Vegesan 2.73 1.0l               ng/mL       0
19628-7 Norfluoxetine PrThr Urine Pt Ord Screen   ACTIVE Norfluoxetine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19628-7   Screen     Both       0 Norfluoxetine Ur Ql Scn           (S)-Norfluoxetine; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; Norfluoxetin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Seproxetine; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19629-5 Norfluoxetine PrThr Urine Pt Ord Confirm   ACTIVE Norfluoxetine [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19629-5   Confirm     Both       0 Norfluoxetine Ur Ql Cfm           (S)-Norfluoxetine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; GCMS; LC/MS/MS; Norfluoxetin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seproxetine; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
1963-8 Bicarbonate SCnc Ser/Plas Pt Qn     ACTIVE Bicarbonate [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     mmol/L             CHEM   1963-8         Both       0 HCO3 SerPl-sCnc       Y   BIC; bicar; Bicarb; Chemistry; HCO3; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SBC; SBIC; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1               mmol/L     Changed from Ser to Ser/Plas since there is no clinical difference in bicarbonate levels in serum or plasma. 0
19630-3 Norfluoxetine cutoff MCnc Urine Pt Qn Screen   ACTIVE Norfluoxetine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19630-3   Screen     Observation       0 Norfluoxetine CtO Ur Scn-mCnc       Y   (S)-Norfluoxetine; CtO; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; Level; Mass concentration; Norfluoxetin; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Seproxetine; UA; UR; Urn 2.42 1.0l               ng/mL       0
19631-1 Norfluoxetine cutoff MCnc Urine Pt Qn Confirm   ACTIVE Norfluoxetine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19631-1   Confirm     Observation       0 Norfluoxetine CtO Ur Cfm-mCnc       Y   (S)-Norfluoxetine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; GCMS; LC/MS/MS; Level; Mass concentration; Norfluoxetin; Point in time; QNT; Quan; Quant; Quantitative; Random; Seproxetine; UA; UR; Urn 2.42 1.0l               ng/mL       0
19632-9 Norpropoxyphene PrThr Urine Pt Ord Screen   ACTIVE Norpropoxyphene [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19632-9   Screen     Both       0 Norpropoxyph Ur Ql Scn           DRUG/TOXICOLOGY; Drugs; n-desmethylproproxyphene; Norpropoxyp; Ordinal; Point in time; PR; Propoxyphene metabolite; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19635-2 Norpropoxyphene MCnc Urine Pt Qn     ACTIVE Norpropoxyphene [Mass/volume] in Urine   MIN DefinitionDescription     ug/mL             DRUG/TOX   19635-2         Both       0 Norpropoxyph Ur-mCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; n-desmethylproproxyphene; Norpropoxyp; Point in time; Propoxyphene metabolite; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l               ug/mL       0
19636-0 Norpropoxyphene cutoff MCnc Urine Pt Qn Screen   ACTIVE Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19636-0   Screen     Observation       0 Norpropoxyph CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; n-desmethylproproxyphene; Norpropoxyp; Point in time; Propoxyphene metabolite; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19637-8 Norpropoxyphene cutoff MCnc Urine Pt Qn Confirm   ACTIVE Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19637-8   Confirm     Observation       0 Norpropoxyph CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; n-desmethylproproxyphene; Norpropoxyp; Point in time; Propoxyphene metabolite; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19638-6 Oxazepam PrThr Urine Pt Ord Screen   ACTIVE Oxazepam [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19638-6   Screen     Both       0 Oxazepam Ur Ql Scn           Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Serax; Temazepam metabolite; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19639-4 Oxazepam PrThr Urine Pt Ord Confirm   ACTIVE Oxazepam [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19639-4   Confirm     Both       0 Oxazepam Ur Ql Cfm           Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Serax; Temazepam metabolite; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
1964-6 Bicarbonate SCnc Urine Pt Qn     ACTIVE Bicarbonate [Moles/volume] in Urine   MIN DefinitionDescription     mmol/L             CHEM   1964-6         Both       0 HCO3 Ur-sCnc       Y   BIC; bicar; Bicarb; Chemistry; HCO3; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.73 1               mmol/L       0
19640-2 Oxazepam cutoff MCnc Urine Pt Qn Screen   ACTIVE Oxazepam cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19640-2   Screen     Observation       0 Oxazepam CtO Ur Scn-mCnc       Y   Alepam; Chlordiazepoxide metabolite; CtO; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Serax; Temazepam metabolite; UA; UR; Urn 2.44 1.0l               ng/mL       0
104,672 results found